-
[Latest] Global Cancer Supportive Care Drugs Market Size/Share Worth USD 32,783.2 Billion by 2033 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
06 May 2024 16:30 GMT
… drugs to manage treatment-related side effects such as pain, nausea, and anemia … Novartis gained FDA approval for Pluvicto to treat adult … treatment-related symptoms and adhering to supportive care drug regimens.
Research and Development: Pharmaceutical …
-
U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
06 May 2024 11:11 GMT
… Food and Drug Administration (FDA) has accepted … formulation. The pharmacokinetics, efficacy and … treatment option across multiple cancers.
Opdivo’s leading global development … 47;immune): hemolytic anemia, aplastic anemia, hemophagocytic lymphohistiocytosis ( …
-
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
06 May 2024 11:11 GMT
… treatment option across multiple cancers.
Opdivo’s leading global development … Food and Drug Administration (FDA) approved Yervoy … 47;immune): hemolytic anemia, aplastic anemia, hemophagocytic lymphohistiocytosis ( … and Ono Pharmaceutical Collaboration
In …
-
Efficacy and Safety of Kuoxin Formula in the Treatment of Dilated Cardiomyopathy-Related Heart Failure: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial
06 May 2024 08:41 GMT
… Western medical treatments for DCM primarily involve pharmaceutical therapy, … treating DCM -related heart failure. It seeks to develop … ,18 this trial adopts conventional Western medications. Eligible patients … based on bioinformatics. MEDS Chin Med. 2022;4(8). …
-
Women Reproductive Health: What Is Anemia? Understand Types, Challenges & More
06 May 2024 07:25 GMT
… health challenges:
Types of Anemia and Their Challenges
1. … such as kidney failure.
Anemia: Diagnosis
"Diagnosis of … the cognitive and physical development of children born to … or chronic forms, treatments may include medications to stimulate red …
-
Hydroxyurea dose escalation enhances clinical outcomes in children with sickle cell anemia: Study
05 May 2024 18:35 GMT
… (REACH) trial unveiled promising results in the treatment of sickle cell anemia among … comprehensive trial illuminates the importance of tailored treatment strategies for sickle cell anemia …
-
Sickle cell: Nigerian Surgeon develops compression therapy for leg ulcers
04 May 2024 09:27 GMT
… Arabia, has developed novel compression therapy for sickle cell anemia chronic leg … said.
Ogunkeyede explained that the treatment had revolutionized the healing process … the widespread adoption of effective treatment strategies,” he said.
Ogunkeyede …
-
J&J reports latest data on Balversa ‘pretzel’ therapy for bladder cancer
06 May 2024 16:56 GMT
Bladder cancer patients with a common mutation saw promising early results after receiving a Johnson & Johnson targeted therapy called Balversa that’s administered through a slow-releasing pretzel-shaped delivery device.
The …
-
Hydroxyurea Dose Escalation Effective for Children with Sickle Cell Anemia
03 May 2024 22:48 GMT
… Drug Administration (FDA), for children and adults with sickle cell anemia … the trial. As of October 2023, patients received treatment … frequent laboratory surveillance and medication expenses. The editorial … testing hydroxyurea to treat sickle cell anaemia …
-
A Decade of Progress: Advances in the Third-Line Treatment of Patients With Metastatic Colorectal Cancer
03 May 2024 23:45 GMT
… positive CRC also may develop metastases eventually.4 … treatments for these patients.26
Best practices for treating … and hypertension; still, this medication may be an option … Medicines Corporation; Boehringer Ingelheim Pharmaceuticals, Inc; Celularity Inc; …